{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:20:36Z","timestamp":1794442836043,"version":"4.9.1"},"publisher-location":"Totowa, NJ","reference-count":35,"publisher":"Humana Press","isbn-type":[{"value":"9781627032681","type":"print"},{"value":"9781627032698","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-269-8_10","type":"book-chapter","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T12:23:30Z","timestamp":1364214210000},"page":"175-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR"],"prefix":"10.1007","author":[{"given":"Christiane","family":"Pott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ritgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kneba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"10_CR00101","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.bbmt.2007.05.012","volume":"13","author":"JR Brown","year":"2007","unstructured":"Brown JR, Feng Y, Gribben JG, Neuberg D, Fisher DC, Mauch P et al (2007) Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission. Biol Blood Marrow Transplant 13:1057\u20131065","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR00102","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1200\/JCO.2009.22.6258","volume":"27","author":"L Goff","year":"2009","unstructured":"Goff L, Summers K, Iqbal S, Kuhlmann J, Kunz M, Louton T et al (2009) Quantitative PCR analysis for Bcl-2\/IgH in a phase III study of Yttrium-90 Ibritumomab Tiuxetan as consolidation of first remission in patients with follicular lymphoma. J Clin Oncol 27:6094\u20136100","journal-title":"J Clin Oncol"},{"key":"10_CR00103","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1200\/JCO.1995.13.5.1073","volume":"13","author":"JE Hardingham","year":"1995","unstructured":"Hardingham JE, Kotasek D, Sage RE, Gooley LT, Mi JX, Dobrovic A et al (1995) Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin\u2019s lymphoma. J Clin Oncol 13:1073\u20131079","journal-title":"J Clin Oncol"},{"key":"10_CR00104","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1044-579X(03)00017-8","volume":"13","author":"C Hirt","year":"2003","unstructured":"Hirt C, Schuler F, Dolken G (2003) Minimal residual disease (MRD) in follicular lymphoma in the era of immunotherapy with rituximab. Semin Cancer Biol 13:223\u2013231","journal-title":"Semin Cancer Biol"},{"key":"10_CR00105","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.bbmt.2006.07.007","volume":"12","author":"M Ladetto","year":"2006","unstructured":"Ladetto M, Magni M, Pagliano G, De Marco F, Drandi D, Ricca I et al (2006) Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma. Biol Blood Marrow Transplant 12:1270\u20131276","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR00106","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/sj.leu.2401242","volume":"12","author":"M Moos","year":"1998","unstructured":"Moos M, Schulz R, Martin S, Benner A, Haas R (1998) The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin\u2019s lymphoma. Leukemia 12:1971\u20131976","journal-title":"Leukemia"},{"key":"10_CR00107","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/JCO.2005.04.021","volume":"23","author":"P Moreton","year":"2005","unstructured":"Moreton P, Kennedy B, Lucas G, Leach M, Rassam SMB, Haynes A et al (2005) Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after Alemtuzumab therapy Is associated with prolonged survival. J Clin Oncol 23:2971\u20132979","journal-title":"J Clin Oncol"},{"key":"10_CR00108","doi-asserted-by":"crossref","unstructured":"Pott C, Hoster E, Beldjord K, Macintyre E, B\u00f6ttcher S, Asnafi V et al (2010) R-CHOP\/R-DHAP prior to autologous stem cell transplantation induces higher rates of molecular remission than R-CHOP in younger patients with MCL: results of the MCL younger intergroup trial of the European MCL Network. Blood 116: abstract 528","DOI":"10.1182\/blood.V116.21.965.965"},{"key":"10_CR00109","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","volume":"115","author":"C Pott","year":"2010","unstructured":"Pott C, Hoster E, Delfau-Larue MH, Beldjord K, Bottcher S, Asnafi V et al (2010) Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. Blood 115:3215\u20133223","journal-title":"Blood"},{"key":"10_CR001010","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood-2005-07-2845","volume":"107","author":"C Pott","year":"2006","unstructured":"Pott C, Schrader C, Gesk S, Harder L, Tiemann M, Raff T et al (2006) Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. Blood 107:2271\u20132278","journal-title":"Blood"},{"key":"10_CR001011","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V88.6.2228.bloodjournal8862228","volume":"88","author":"D Provan","year":"1996","unstructured":"Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P et al (1996) Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 88:2228\u20132235","journal-title":"Blood"},{"key":"10_CR001012","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","volume":"112","author":"CH Geisler","year":"2008","unstructured":"Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M et al (2008) Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 112:2687\u20132693","journal-title":"Blood"},{"key":"10_CR001013","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1182\/blood-2007-10-116749","volume":"111","author":"M Ladetto","year":"2008","unstructured":"Ladetto M, De Marco F, Benedetti F, Vitolo U, Patti C, Rambaldi A et al (2008) Prospective, multicenter randomized GITMO\/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. Blood 111:4004\u20134013","journal-title":"Blood"},{"key":"10_CR001014","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","volume":"105","author":"A Rambaldi","year":"2005","unstructured":"Rambaldi A, Carlotti E, Oldani E, Della SI, Baccarani M, Cortelazzo S et al (2005) Quantitative PCR of bone marrow BCL2\/IgH positive cells at diagnosis predicts treatment response and long-term outcome in Follicular non Hodgkin\u2019s Lymphoma. Blood 105:3428\u20133433","journal-title":"Blood"},{"key":"10_CR001015","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0301-472X(02)00807-X","volume":"30","author":"NS Andersen","year":"2002","unstructured":"Andersen NS, Donovan JW, Zuckerman A, Pedersen L, Geisler C, Gribben JG (2002) Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1\/JH rearrangements in mantle cell lymphoma. Exp Hematol 30:703\u2013710","journal-title":"Exp Hematol"},{"key":"10_CR001016","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1200\/JCO.2008.21.3116","volume":"27","author":"NS Andersen","year":"2009","unstructured":"Andersen NS, Pedersen LB, Laurell A, Elonen E, Kolstad A, Boesen AM et al (2009) Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma. J Clin Oncol 27:4365\u20134370","journal-title":"J Clin Oncol"},{"key":"10_CR001017","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood.V99.3.856","volume":"99","author":"A Rambaldi","year":"2002","unstructured":"Rambaldi A, Lazzari M, Manzoni C, Carlotti E, Arcaini L, Baccarani M et al (2002) Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood 99:856\u2013862","journal-title":"Blood"},{"key":"10_CR001018","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.leu.2404479","volume":"21","author":"PAS Evans","year":"2006","unstructured":"Evans PAS, Pott C, Groenen PJTA, Salles G, Davi F, Berger F et al (2006) Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21:207\u2013214","journal-title":"Leukemia"},{"key":"10_CR001019","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"key":"10_CR001020","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ijc.2910450406","volume":"45","author":"M Kneba","year":"1990","unstructured":"Kneba M, Bergholz M, Bolz I, Hulpke M, Batge R, Schauer A et al (1990) Heterogeneity of immunoglobulin gene rearrangements in B-cell lymphomas. Int J Cancer 45:609\u2013613","journal-title":"Int J Cancer"},{"key":"10_CR001021","first-page":"3243","volume":"51","author":"M Kneba","year":"1991","unstructured":"Kneba M, Eick S, Herbst H, Willigeroth S, Pott C, Bolz I et al (1991) Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin\u2019s lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res 51:3243\u20133250","journal-title":"Cancer Res"},{"key":"10_CR001022","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/sj.leu.2401172","volume":"12","author":"C Pott","year":"1998","unstructured":"Pott C, Tiemann M, Linke B, Ott MM, von Hofen M, Bolz I et al (1998) Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas. Leukemia 12:1630\u20131637","journal-title":"Leukemia"},{"key":"10_CR001023","doi-asserted-by":"crossref","unstructured":"van der Velden V, van Dongen J (2009) MRD detection in acute lymphoblastic leukemia patients using Ig\/TCR gene rearrangements as targets for real-time quantitative PCR. In: Walker JM (ed) Lymphoma: methods and protocols. Humana Press, p. 115\u2013150","DOI":"10.1007\/978-1-59745-418-6_7"},{"key":"10_CR001024","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/sj.leu.2401575","volume":"13","author":"K Olsson","year":"1999","unstructured":"Olsson K, Gerard CJ, Zehnder J, Jones C, Ramanathan R, Reading C et al (1999) Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD). Leukemia 13:1833\u20131842","journal-title":"Leukemia"},{"issue":"Suppl. 5","key":"10_CR001025","first-page":"162","volume":"26","author":"C Pott","year":"2003","unstructured":"Pott C, Schrader C, Trautmann H, Irmer S, Desgranges C, Ritgen M et al (2003) VH mutational status and VH gene usage define molecular heterogeneity in mantle cell lymphoma. Onkologie 26(suppl 5):162","journal-title":"Onkologie"},{"key":"10_CR001026","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","volume":"17","author":"VH van der Velden","year":"2003","unstructured":"van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ (2003) Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 17:1013\u20131034","journal-title":"Leukemia"},{"key":"10_CR001027","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VHJ van der Velden","year":"2007","unstructured":"van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER et al (2007) Analysis of minimal residual disease by Ig\/\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604\u2013611","journal-title":"Leukemia"},{"key":"10_CR001028","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2141.2011.08803.x","volume":"155","author":"K Payne","year":"2011","unstructured":"Payne K, Wright P, Grant JW, Huang Y, Hamoudi R, Bacon CM et al (2011) BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma. Br J Haematol 155:84\u201392","journal-title":"Br J Haematol"},{"key":"10_CR001029","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.leu.2401831","volume":"14","author":"M Bruggemann","year":"2000","unstructured":"Bruggemann M, Droese J, Bolz I, Luth P, Pott C, von Neuhoff N et al (2000) Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 14:1419\u20131425","journal-title":"Leukemia"},{"key":"10_CR001030","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood.V95.8.2651","volume":"95","author":"JW Donovan","year":"2000","unstructured":"Donovan JW, Ladetto M, Zou G, Neuberg D, Poor C, Bowers D et al (2000) Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. Blood 95:2651\u20132658","journal-title":"Blood"},{"key":"10_CR001031","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<17::AID-GCC4>3.0.CO;2-B","volume":"21","author":"T Akasaka","year":"1998","unstructured":"Akasaka T, Akasaka H, Yonetani N, Ohno H, Yamabe H, Fukuhara S, Okuma M (1998) Refinement of the BCL2\/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer 21:17\u201329","journal-title":"Genes Chromosomes Cancer"},{"key":"10_CR001032","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/sj.leu.2401889","volume":"14","author":"G Buchonnet","year":"2000","unstructured":"Buchonnet G, Lenain P, Ruminy P, Lepretre S, Stamatoullas A, Parmentier F et al (2000) Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3\u2032 BCL2 breakpoints and evidence of a new cluster. Leukemia 14:1563\u20131569","journal-title":"Leukemia"},{"key":"10_CR001033","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","volume":"160","author":"A Albinger-Hegyi","year":"2002","unstructured":"Albinger-Hegyi A, Hochreutener B, Abdou MT, Hegyi I, Dours-Zimmermann MT, Kurrer MO et al (2002) High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 160:823\u2013832","journal-title":"Am J Pathol"},{"key":"10_CR001034","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.leu.2404467","volume":"21","author":"JHJM van Krieken","year":"2006","unstructured":"van Krieken JHJM, Langerak AW, Macintyre EA, Kneba M, Hodges E, Sanz RG et al (2006) Improved reliability of lymphoma diagnostics via PCR-based clonality testing: [mdash] Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21:201\u2013206","journal-title":"Leukemia"},{"key":"10_CR001035","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","volume":"12","author":"MJ Pongers-Willemse","year":"1998","unstructured":"Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E et al (1998) Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 12:2006\u20132014","journal-title":"Leukemia"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-269-8_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T03:12:12Z","timestamp":1676776332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-269-8_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"ISBN":["9781627032681","9781627032698"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-269-8_10","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-62703-269-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]},"assertion":[{"value":"30 October 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}